Acitemate
CAS No. 64405-40-9
Acitemate( —— )
Catalog No. M36140 CAS No. 64405-40-9
Acitemate(Chinoin 123) has an inhibitory effect on atherosclerosis and reduces the permeability of the aorta in rabbits fed a hyperlipidemic diet, which can be used to study atherosclerosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 713 | In Stock |
|
| 10MG | 1074 | In Stock |
|
| 25MG | 1937 | In Stock |
|
| 50MG | 2744 | In Stock |
|
| 100MG | 4111 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAcitemate
-
NoteResearch use only, not for human use.
-
Brief DescriptionAcitemate(Chinoin 123) has an inhibitory effect on atherosclerosis and reduces the permeability of the aorta in rabbits fed a hyperlipidemic diet, which can be used to study atherosclerosis.
-
DescriptionAcitemate(Chinoin 123) has an inhibitory effect on atherosclerosis and reduces the permeability of the aorta in rabbits fed a hyperlipidemic diet, which can be used to study atherosclerosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number64405-40-9
-
Formula Weight294.3
-
Molecular FormulaC14H18N2O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C(O)=O)C1C=2N(C(=O)C(C(OCC)=O)=CN2)C(C)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Pyrabactin
Pyrabactin is a seed-selective abscisic acid (ABA) agonist, Novel PYL agonist; acting as a plant growth inhibitor.
-
SH2 Domain Ligand (4...
SH2 Domain Ligand (4)
-
Egg yolk phosphatidy...
Lecithins, egg can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.
Cart
sales@molnova.com